UC AKT.ANL. 09/24 AMD/ DE000HVB85K4 /
2024-04-30 7:12:29 PM | Chg.0.000 | Bid2024-04-30 | Ask2024-04-30 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
102.180EUR | 0.00% | 101.370 Bid Size: 50,000 |
102.390 Ask Size: 50,000 |
Advanced Micro Devic... | 81.192 USD | 2024-09-19 | Call |
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
05-01
Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...
GlobeNewswire
05-01
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire
05-01
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
GlobeNewswire
05-01
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology ...
GlobeNewswire
04-30
Lighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)
GlobeNewswire
04-25
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire
04-18
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
GlobeNewswire
04-16
AMD Expands Commercial AI PC Portfolio to Deliver Leadership Performance Across Professional Mobile ...